influenza — grants · GrantIndex

Sort

21,281 grants matching “influenza”

Point of care microfluidic diagnosis system for rapid and sensitive detection of

$737,477

Michel G. Bergeron · Laval University · R01 · FY2013 · AI

Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination

$737,115

Sara Lustigman · New York Blood Center · U01 · FY2021 · AI

Idaho INBRE SARS-CoV-2 variant surveillance using viral genome sequencing and analyses

$737,106

Carolyn Hovde Bohach · University Of Idaho · P20 · FY2021 · GM

Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza

$737,051

Lauren Ancel Meyers · University Of Texas At Austin · U01 · FY2021 · IP

REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos

$736,867

Kathleen R Page · Johns Hopkins University · R01 · FY2025 · MD

REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos

$736,844

Kathleen R Page · Johns Hopkins University · R01 · FY2022 · MD

Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses

$736,800

Alexander Bukreyev · University Of Texas Med Br Galveston · R01 · FY2014 · AI

STRENGTHENING THAILAND'S INFLUENZA SURVEILLANCE NETWORK TO SUPPORT INFLUENZA CONT

$736,777

Pathom Sawanpanyalert · National Institute Of Health · U51 · FY2009 · IP

The VesiVaxÂ® System: Vaccine Development Made Easy

$736,747

Samon Ho · Molecular Express, Inc. · R44 · FY2017 · AI

REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos

$736,639

Kathleen R Page · Johns Hopkins University · R01 · FY2023 · MD

Inflammation and Therapy for Respiratory Virus Infection

$736,532

Helene Rosenberg · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Vanderbilt Vaccine and Treatment Evaluation Unit

$736,417

Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2020 · AI

The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity

$735,994

Sixto Manuel Leal · University Of Alabama At Birmingham · R01 · FY2024 · AI

Clinical Studies of Vaccines for Pandemic H1N1 Influenza

$735,980

Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

$735,422

Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2023 · AI

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

$735,422

Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2021 · AI

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

$735,422

Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2024 · AI

Mathmatical models for immune signatures from population- and single-cell-base an

$735,066

Steven H. Kleinstein · Yale University · U19 · FY2012 · AI

Computational design and development of small protein inhibitors

$734,649

Eva-Maria Strauch · Washington University · R01 · FY2025 · AI

Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.

$734,219

Jose M Galarza · Technovax, Inc. · R44 · FY2019 · AI

Development of a Universal Influenza Vaccine

$734,209

Frank R. Jones · Etubics Corporation · R01 · FY2018 · AI

Point of care microfluidic diagnosis system for rapid and sensitive detection of

T5000 Diagnostic System in Ferret Model of Influenza

Immune Responses To HIV And Other Pathogens

Loss of Endothelial S1PR1 Drives Post-Influenza Pulmonary Fibrosis

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination

Idaho INBRE SARS-CoV-2 variant surveillance using viral genome sequencing and analyses

Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza

REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos

REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos

Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses

STRENGTHENING THAILAND'S INFLUENZA SURVEILLANCE NETWORK TO SUPPORT INFLUENZA CONT

The VesiVaxÂ® System: Vaccine Development Made Easy

REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos

Inflammation and Therapy for Respiratory Virus Infection

Vanderbilt Vaccine and Treatment Evaluation Unit

The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity

Clinical Studies of Vaccines for Pandemic H1N1 Influenza

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

Mathmatical models for immune signatures from population- and single-cell-base an

Computational design and development of small protein inhibitors

Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.

Development of a Universal Influenza Vaccine